BioSpace News Archive

Addex Therapeutics Ltd announced that patient enrollment has been completed in its Phase 2a clinical study evaluating dipraglurant as a potential treatment for blepharospasm, a type of dystonia characterized by involuntary contractions or spasms of the eyelid muscles.

International medical imaging IT and cybersecurity company Sectra has signed a contract with North York General Hospital in Canada.

Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Halozyme will acquire Antares for $5.60 per share in cash.

Zomedica Corp. is pleased to announce that the PulseVet system has been named the Official Shock Wave Therapy of the American Quarter Horse Association.

VantAI, an AI-first induced-proximity company, today announced it has entered into a multi-year collaboration agreement with Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (‘Janssen’).

Coeptis Therapeutics, Inc. today announced that the Company has entered into a strategic agreement with Statera Biopharma, Inc.

MitoQ Ltd. today announced a complete transformation of the brand with a fresh new design, updated visual language and sustainable packaging.

Sonnet BioTherapeutics Holdings, Inc., announced today that dosing has been initiated in a Phase 1 clinical trial of SON-1010 (IL12-F H AB) in adult patients with advanced solid tumors.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that its clinical validation study1 on its donor-derived cell-free DNA (dd-cfDNA) test for the assessment of acute rejection in heart transplant patients, Prospera™ Heart, has been published in the Journal of Heart and Lung Transplantation - a leading journal with the highest impact factor in the transplantation sector.

Appili Therapeutics Inc. today announced the addition of ATI-1801, a clinical stage topical paromomycin product to treat cutaneous leishmaniasis, to its development pipeline.